Morio Ueyama Selected Research

alpha-Synuclein

1/2018

Parkinson's disease-linked DNAJC13 mutation aggravates alpha-synuclein-induced neurotoxicity through perturbation of endosomal trafficking.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morio Ueyama Research Topics

Disease

3	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2018
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 11/2021 - 04/2017
1	Frontotemporal Dementia (Semantic Dementia) 12/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2023
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2019
1	Synucleinopathies 01/2019
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2018
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2018
1	Motor Neuron Disease (Primary Lateral Sclerosis) 04/2017
1	Proteostasis Deficiencies 04/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2015
2	SynucleinsIBA 01/2019 - 01/2019
1	NucleotidesIBA 12/2023
1	CarbamatesIBA 11/2021
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2019
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2019
1	alpha-SynucleinIBA 01/2018
1	NucleophosminIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 04/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2017
1	Ubiquitinated ProteinsIBA 01/2015
1	polyglutamineIBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2018